Literature DB >> 15065096

Natural history and long-term outcome of cardiac rhabdomyomas detected prenatally.

Vlasta Fesslova1, Laura Villa, Tommaso Rizzuti, Massimo Mastrangelo, Fabio Mosca.   

Abstract

OBJECTIVES: To analyse the data of fetal cases with rhabdomyomatosis, the growth of masses in utero, and the relative outcome.
MATERIAL AND METHODS: Thirteen cases of cardiac/pericardial tumours with characteristics suggesting rhabdomyomatosis were found in our centre on fetal echocardiography, five before 24 wg (group A) and eight (group B) at 25 to 36 wg. Four patients terminated the pregnancy, nine continued the pregnancy and were followed-up until delivery and after birth (median postnatal follow-up of 4.2 years, range 18 months-16 years).
RESULTS: In six/nine cases that continued the pregnancy (66.7%), the growth of smaller tumor masses was proportional with gestational age until 30 to 32 wg and was stable after that. In three cases, larger masses grew disproportionally and other small masses were revealed, causing a partial obstruction of outflow tracts. After birth, no case required surgery and no serious rhythm problems occurred. Cardiac masses regressed at least partially in all cases. Tuberous sclerosis was diagnosed in 9/11 cases (81.1%) investigated by magnetic resonance imaging in utero or postnatally. One case also had bilateral polycystic kidneys.
CONCLUSIONS: Multiple and larger noduli progressed disproportionally in utero, until 30 to 36 wg. No relevant cardiac problems occurred after birth and the masses regressed in all cases. The high frequency of association with tuberous sclerosis is confirmed in our series. Copyright 2004 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2004        PMID: 15065096     DOI: 10.1002/pd.825

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  11 in total

1.  Fetal demise secondary to massive rhabdomyoma in the early second trimester of pregnancy.

Authors:  J Sharma; S Inglis; R Cavalieri; I Udom-Rice
Journal:  Pediatr Cardiol       Date:  2010-12-25       Impact factor: 1.655

2.  Different information by MRI compare to ultrasound in fetal intracranial space occupying lesions.

Authors:  Wei Xia; Gregor Kasprian; Daoyu Hu; Peng Xiao; Wenzhong Yang; Xinlin Chen
Journal:  Childs Nerv Syst       Date:  2017-07-10       Impact factor: 1.475

Review 3.  Tumours of the fetal body: a review.

Authors:  Fred E Avni; Anne Massez; Marie Cassart
Journal:  Pediatr Radiol       Date:  2009-02-24

4.  Implantable cardioverter defibrillator as a bridge to recovery in an infant with cardiac rhabdomyoma.

Authors:  Priya Chockalingam; Sally-Ann B Clur; Arthur A M Wilde; Irene Kuipers; Job van Woensel; Nico A Blom
Journal:  Eur J Pediatr       Date:  2008-09-25       Impact factor: 3.183

5.  Maternal Sirolimus Therapy for Fetal Cardiac Rhabdomyomas.

Authors:  Benjamin T Barnes; David Procaccini; Jude Crino; Karin Blakemore; Priya Sekar; Katelynn G Sagaser; Angie C Jelin; Lasya Gaur
Journal:  N Engl J Med       Date:  2018-05-10       Impact factor: 91.245

6.  Congenital tumors: imaging when life just begins.

Authors:  Leonor Alamo; Maja Beck-Popovic; François Gudinchet; Reto Meuli
Journal:  Insights Imaging       Date:  2011-02-14

7.  Right atrial cardiac rhabdomyoma with premature foramen ovale restriction: A case report.

Authors:  Yi-Dan Li; Yi-Hua He; Zhi-An Li; Ping Wei
Journal:  Oncol Lett       Date:  2014-10-10       Impact factor: 2.967

8.  Hypoplastic left heart syndrome secondary to intrauterine rhabdomyoma necessitating single ventricle palliation.

Authors:  Arshid Mir; Catherine Minor Ikemba; Surendranath R Veeram Reddy
Journal:  Ann Pediatr Cardiol       Date:  2014-09

9.  Prenatally Diagnosis and Outcome of Fetuses with Cardiac Rhabdomyoma - Single Centre Experience.

Authors:  Ramush Bejiqi; Ragip Retkoceri; Hana Bejiqi
Journal:  Open Access Maced J Med Sci       Date:  2017-03-20

10.  Rhabdomyoma and Hypoplastic Left Heart Syndrome - Case Report of a Very Rare Combination.

Authors:  Rahaf Waggass; Hanan S Bin Yahib; Hosam H Bin Seddeq; Aiman Shawli
Journal:  Cureus       Date:  2021-11-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.